Global Pharmaceuticals & Biotech High Return On Equity, Low Debt

Roche Holding

Market Cap: CHF 282.2b

Engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand.

Gilead Sciences

Market Cap: US$163.0b

A biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.

Exelixis

Market Cap: US$14.1b

An oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States.

Orion Oyj

Market Cap: €11.4b

Develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, rest of Europe, North America, and internationally.

RemeGen

Market Cap: HK$63.3b

A biopharmaceutical company, discovers, develops, produces, and commercializes biological drugs for the treatment of autoimmune, oncology, and ophthalmic diseases in Mainland China and the United States.

Shanghai Allist Pharmaceuticals

Market Cap: CN¥50.0b

A pharmaceutical company, engages in the research and development of tumor-targeted drugs in China in internationally.

Abbott India

Market Cap: ₹590.4b

Operates as a pharmaceutical company in India.

Sunshine Guojian Pharmaceutical (Shanghai)

Market Cap: CN¥36.6b

A biopharmaceutical company, engages in the research and development, production, and sale of antibody drugs.

GlaxoSmithKline Pharmaceuticals

Market Cap: ₹449.5b

Manufactures, distributes, and trades in pharmaceuticals in India and internationally.

ACADIA Pharmaceuticals

Market Cap: US$4.5b

A biopharmaceutical company, focuses on the development and commercialization of medicines for neurological and rare disease in North America.

SK Biopharmaceuticals

Market Cap: ₩6.2t

A pharmaceutical company, engages in the research, development, and commercialization of drugs for the treatment of central nervous system disorders.

Sumitomo Pharma

Market Cap: JP¥559.8b

Manufactures, purchases, and sells pharmaceutical products for medical treatment in Japan, North America, and Asia.

Zealand Pharma

Market Cap: DKK 21.4b

A biotechnology company, engages in the discovery, development, and commercialization of peptide-based medicines in Denmark and the United States.

Shenyang Xingqi PharmaceuticalLtd

Market Cap: CN¥15.2b

Engages in the research, development, production, and sale of ophthalmic drugs in the People’s Republic of China.

ADMA Biologics

Market Cap: US$2.0b

A biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally.

Innoviva

Market Cap: US$1.6b

Operates as a biopharmaceutical company in the United States and internationally.

BioGaia

Market Cap: SEK 11.7b

A healthcare company, develops, manufactures, markets and sells probiotic products for gut, oral, and immune health in Europe, the Middle East, Africa, the United States, the Asia-Pacific, Australia, and New Zealand.

Theravance Biopharma

Market Cap: US$873.6m

A biopharmaceutical company, develops and commercializes medicines in the United States.

Center Laboratories

Market Cap: NT$28.2b

A pharmaceutical company, develops, manufactures, and sells pharmaceuticals in Taiwan and internationally.

Sanofi India

Market Cap: ₹76.5b

Manufactures and trades in drugs and pharmaceutical products in India, Singapore and internationally.

Oscotec

Market Cap: ₩1.1t

Operates as a biotechnology company, engages in the drug development, functional materials and related products, and dental bone graft material businesses.

Basilea Pharmaceutica

Market Cap: CHF 643.3m

A Swiss commercial-stage biotech company focused on developing and commercializing treatments for severe bacterial and fungal infections.

CorMedix

Market Cap: US$564.1m

A biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States.

Rafa Laboratories

Market Cap: ₪1.6b

A pharmaceutical company, manufactures, markets, and distributes prescription (Rx) and over-the-counter (OTC) medicines in Israel.

Qyuns Therapeutics

Market Cap: HK$3.6b

A clinical-stage biotech company, engages in the research and development of biologic therapies for autoimmune and allergic diseases in China.

Elite Pharmaceuticals

Market Cap: US$401.4m

A specialty pharmaceutical company, engages in the development, manufacture, and sale of oral, controlled-release products, and generic pharmaceuticals.

Abeona Therapeutics

Market Cap: US$368.8m

A commercial-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases in the United States.

Hester Biosciences

Market Cap: ₹21.1b

Manufactures and trades in veterinary vaccines and health products in India and internationally.

Compugen

Market Cap: US$220.9m

A clinical-stage therapeutic discovery and development company, engages in the research, development, and commercialization of therapeutics and product candidates in Israel, the United States, and Europe.

Saniona

Market Cap: SEK 1.9b

A clinical-stage biopharmaceutical company, focuses on discovering, developing, and delivering innovative treatments for neurological and psychiatric disorders in Ireland, the United States, Germany, Denmark, and the United Kingdom.

Oramed Pharmaceuticals

Market Cap: US$168.6m

Engages in the research and development of pharmaceutical solutions with a technology platform for the oral delivery of therapeutic proteins.

Quality Chemical Industries

Market Cap: USh587.8b

Engages in the manufactures and sells pharmaceutical drugs in Uganda.

Hoechst Pakistan

Market Cap: PK₨38.7b

Together with its subsidiary, manufactures, sells, and trades in pharmaceutical and related products in Pakistan, Afghanistan, and internationally.

Kahira Pharmaceuticals & Chemical Industries

Market Cap: ج.م6.9b

Manufactures, packages, distributes, and trades in pharmaceutical products in Egypt and internationally.

BLS Pharmaceuticals

Market Cap: AU$186.3m

Manufactures and distributes therapeutic goods, and health and wellness products in Australia, the United States, the United Kingdom, Czech Republic, and Japan.

Vaxart

Market Cap: US$127.2m

A clinical-stage biotechnology company, discovers and develops oral recombinant protein vaccines based on its vector-adjuvant-antigen standardized technology proprietary oral vaccine platform.